Yes. If your results are from the last 2–3 months, the endocrinologist reviews them as is — no retesting needed. If something is missing, you get a short list of add-on tests.

In the SURMOUNT-4 trial (JAMA 2024), participants who switched to placebo after 36 weeks regained an average of +14.0% of body weight over a year, while those who continued tirzepatide lost a further 5.5%. That is why discontinuation should be planned: a gradual wind-down, consolidated eating habits and marker monitoring are part of the support programme.

The key tools are sufficient protein (roughly 1.2–1.6 g per kg of body weight; the endocrinologist calculates your individual number for your diet) and resistance training 2–3 times a week. The written protocol spells this out specifically for you.

The most common cause is rapid weight loss and deficiencies (ferritin, protein, zinc, vitamin D), not the medication itself. That is why ferritin and vitamin D are in the baseline panel: deficiencies are corrected before they become a visible problem.

These are the most frequent accompanying effects at the start and after a dose increase. Smaller portions, less fatty food, enough water and not lying down right after meals usually help. If symptoms are strong, the endocrinologist slows down the titration. Injection rules are in the Mounjaro instructions.

Online, via video or audio — whichever suits you. Before the call you fill in a health-history questionnaire, during it you go through your labs and an action plan, and afterwards you receive a written protocol plus 7 days of follow-up questions in chat. Booking — via the form on this page or a manager.

No. The support programme was created precisely for those who already bought tirzepatide (Mounjaro, Tirzetta, Biopatid), semaglutide (Ozempic) or Retatrutide elsewhere. Where the medication came from does not matter; what matters is that the course runs under marker monitoring. INN overview — on the tirzepatide page.

Free DOZA support answers general questions about the course, injections and storage, and runs basic screening. The consultation and the support programme are personal work by a diploma-certified endocrinologist: a review of your own lab results, a written protocol and a month of guidance. You can start with a free consultation.

Yes. The same diploma-certified endocrinologist supports courses on semaglutide (Ozempic), tirzepatide analogues (Biopatid, Tirzetta) and research-grade Retatrutide — lab review, manufacturer-schedule titration and nutrition correction. Format and prices match tirzepatide support. More: Ozempic, Biopatid, Retatrutide.

The support logic is the same: labs, titration, nutrition, deficiencies. What differs are the manufacturer dose-escalation schedules (KwikPen vs FlexTouch) and expected weight dynamics from clinical data. During the consultation the endocrinologist adapts the protocol to your medication — you do not need a different service format.